Navigation Links
Ampio Pharmaceuticals to Present at Upcoming Investor Conference
Date:11/15/2013

GREENWOOD VILLAGE, Colo., Nov. 15, 2013 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that the company is scheduled to present a corporate update at the following upcoming investor conference:

Piper Jaffray 25th Annual Healthcare Conference
Presentation: Tuesday, December 3, 2013 at 10:10 AM EST at the New York Palace Hotel in New York, New York (Kennedy 1 Room)
Presenting: Michael Macaluso, Chairman & Chief Executive Officer & Dr. Vaughan Clift, Chief Regulatory Affairs Officer

(Logo: http://photos.prnewswire.com/prnh/20120516/MM09116LOGO)

Ampio will webcast this management presentation, and the presentation may be accessed through the Company's website, www.ampiopharma.com, on the "Events and Presentations' page. An archived version of the presentation will be available for 90 days.

About Ampio Pharmaceuticals
Ampio Pharmaceuticals, Inc. is a development stage biopharmaceutical company primarily focused on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. We are developing compounds that decrease inflammation by (i) inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; (ii) activating specific phosphatase or depletion of the available phosphate needed for the inflammation process; and (iii) decreasing vascular permeability.

Investor Contact:
Rick Giles
Director of Investor Relations
Ampio Pharmaceuticals, Inc.
Direct (720) 437-6530
Email: rgiles@ampiopharma.com


'/>"/>

SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Ampio Pharmaceuticals, Inc. States that its Policy is Not to Comment on Unusual Market Activity
2. Ampio Pharmaceuticals subsidiary Luoxis Diagnostics announces positive summary data from study of traumatic brain injury patients and issuance of companys third US patent for its oxidation-reduction potential diagnostic platform
3. Ampio Pharmaceuticals, Inc. Announces Additional Positive Results for Ampion(TM) in Osteoarthritis of the Knee Clinical Trial
4. Ampio Pharmaceuticals, Inc. Announces $25 Million Financing
5. Astellas to Host Executive Womens Day at 2013 TOUR Championship by Coca-Cola
6. Ampio Pharmaceuticals, Inc. Announces Positive Results for Ampion in Osteoarthritis of the Knee Clinical Trial
7. Levine Leichtman Acquires Champion Manufacturing
8. Pro Athletes Team Up to Champion Gout Awareness
9. Dr. Helen Fisher to Speak at Astellas Presents Executive Womens Day at the Constellation SENIOR PLAYERS Championship
10. Ampio Pharmaceuticals Issues Statement Regarding Misleading Blog
11. Ampio Pharmaceuticals to List on the NYSE MKT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 2014 Arbor Pharmaceuticals, LLC. - Product ... Markets Direct,s, ,Arbor Pharmaceuticals, LLC. - Product Pipeline ... Arbor Pharmaceuticals, LLC.,s pharmaceutical research and development focus. ... current therapeutic developmental pipeline of Arbor Pharmaceuticals, LLC.,s, ... assessment by drug target, mechanism of action (MoA), ...
(Date:9/30/2014)... Sept. 30, 2014  According to their CEO, ... cancer clinical trials is going through a complete ... the work of the current clinical trial management ... ,next generation, clinical trials, which will ultimately drive ... The company has been recognized by the ...
(Date:9/30/2014)... A study using a relatively new imaging ... at the composition of carotid artery disease and has ... the disease, a leading cause of stroke. ... September 2010 and May 2012, was featured in the ... American College of Cardiology (JACC) Cardiovascular Interventions. Interventional ...
Breaking Medicine Technology:Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014 2Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014 3Small Denver Company Pharmatech driving a large revolution in how cancer clinical trials are managed 2New Imaging Tool May Allow Tailoring of Stroke Prevention to Each Patient 2
... HAYWARD, Calif., Oct. 26 Anthera Pharmaceuticals, Inc. (Nasdaq: ... to treat serious diseases associated with inflammation, today announced ... after market close on Tuesday, November 2, 2010.  Anthera ... Time in conjunction with the release.Conference Call Access:Date: , ...
... Oct. 26 Lexicon Pharmaceuticals, Inc. (Nasdaq: ... discovering breakthrough treatments for human disease, announced today that ... on Friday, November 5, 2010 before the financial markets ... discuss its clinical development progress and financial results for ...
Cached Medicine Technology:Anthera Announces Third Quarter 2010 Financial Report and Conference Call 2Lexicon to Provide Clinical Pipeline Update and Report Third Quarter 2010 Financial Results 2
(Date:9/30/2014)... 2014 Integrated Medicine Alliance , ... another new medical specialty practice through a unique partnership ... will be located within the company’s Shrewsbury location and ... Isaac Tawfik of American Heart Center, P.C., a highly ... will offer Integrated Medicine Alliance patients top notch cardiovascular ...
(Date:9/30/2014)... University of Maryland-led research team has been awarded ... Institutes of Health (NIH) to develop new imaging ... our understanding of how large networks of neurons ... This knowledge will help researchers identify the precise ... behavior, like decision-making and speaking, and alterations in ...
(Date:9/30/2014)... Vegas, NV (PRWEB) September 30, 2014 ... is helping people perform better in and out of the ... and memory has caught the attention of Shane Michaels, prompting ... day-to-day grind, fatigue is the reason most people simply just ... whether that means staying focused at work, getting the motivation ...
(Date:9/30/2014)... 2014 Hospice & Palliative Care ... Celebration” gala, honoring three outstanding individuals for their ... to provide extraordinary and dignified comfort, care and ... or life-limiting illness. , The event was held ... and recognized William (Bill) J. McGuinness, Director of ...
(Date:9/30/2014)... SHELBY TOWNSHIP, Mich. (PRWEB) September 30, 2014 ... inventive chronic knee pain program of care ... patients. , His clinic—Johnson Chiropractic Neurology & ... focusing on the knee. It also addresses sources of ... as well as the “neurokinetic chain” from the brain ...
Breaking Medicine News(10 mins):Health News:Integrated Medicine Alliance Announces New Cardiology Practice 2Health News:UMD receives inaugural BRAIN Initiative Award 2Health News:Elevate: Review Exposes Blue Star Nutraceutical’s Latest Supplement for Ultimate Brain Function, Focus, and Energy 2Health News:Hospice & Palliative Care of Westchester Honors Outstanding Individuals at Annual ‘In Celebration’ Gala 2Health News:Newly Developed Program Eases Chronic Knee Pain without Surgery and in as Little as Two Days 2Health News:Newly Developed Program Eases Chronic Knee Pain without Surgery and in as Little as Two Days 3
... March 17 /PRNewswire/ - Organogenesis, Inc., announced,today ... has joined the company as,vice president of ... Dr. Bates combines more than twelve ... industry experience. He has practiced in,orthopedic, dermatologic, ...
... The neighborhoods people live in can help inspire ... physically active, new research suggests. , Residents of neighborhoods ... female-headed families are less likely than others to exercise, ... poorer people are less likely to exercise, researchers say. ...
... the 2008 Presidential election campaign so now is a critical ... the future and the challenges our society will face as ... professor of Health Law, Bioethics, and Human Rights at BUSPH ... These challenges include integrating the new genetics into care, improving ...
... Blood Testing Requirements, VANCOUVER, March 17 /PRNewswire-FirstCall/ ... that the U.S. Food and Drug Administration (FDA),has ... supplement (sNDA) for,Aczone(TM) and has removed the glucose-6-phosphate ... are extremely pleased to report the FDA decision ...
... the Need Is Still There, WASHINGTON, March 17 ... still suffering emotionally from the,effects of the storms will ... Red Cross Hurricane Recovery Program (HRP) has,announced it will ... May 31, 2008. The Red Cross Emotional Support Program,allows ...
... 17 Hologic, Inc.,(Nasdaq: HOLX ) today announced ... Officer, will be presenting at the Lehman,Brothers Eleventh Annual ... Miami Beach Hotel in Miami, Florida., Interested parties ... of,Hologic,s investor presentation on Thursday, March 20, at 10:15 ...
Cached Medicine News:Health News:Organogenesis Names Regenerative Medicine Expert Dr. Damien Bates Vice President, Medical Affairs 2Health News:Organogenesis Names Regenerative Medicine Expert Dr. Damien Bates Vice President, Medical Affairs 3Health News:Neighborhoods play key role in how much people exercise, study says 2Health News:Neighborhoods play key role in how much people exercise, study says 3Health News:BU's School of Law, Public Health to hold conference on the future of health law 2Health News:QLT announces positive FDA action on Aczone(TM) 2Health News:QLT announces positive FDA action on Aczone(TM) 3Health News:Red Cross Announces an Extension for Emotional Support Assistance for 2005 Hurricane Survivors 2Health News:Hologic to Present at Lehman Brothers Healthcare Conference 2
... 5mm AEM Laparoscopic Instruments incorporate a layered ... are shielded and monitored to prevent stray ... instrument caused by insulation failure or capacitive ... protective shield built into all AEM Instruments ...
... The 5mm AEM Laparoscopic Instruments incorporate ... AEM Instruments are shielded and monitored to ... of the instrument caused by insulation failure ... risk. The protective shield built into all ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
... Enhanced features including aspiration holes ... in laparoscopic procedures requiring precise dissection ... and increased suction demands. ,Flexible ... retractable and nonretractable electrodes and multiple ...
Medicine Products: